Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Daptomycin and vancomycin heteroresistance revealed among CC5-SCCmecII MRSA clone and in vitro evaluation of treatment alternatives.

Journal of global antimicrobial resistance - 1 Sept 2018

Okado Jessica Baleiro, Avaca-Crusca Juliana Sposto, Oliveira Alexandre Lima, Dabul Andrei Nicoli Gebieluca, Camargo Ilana Lopes Baratella da Cunha

Abstract excerpt

OBJECTIVES: Methicillin-resistant Staphylococcus aureus (MRSA) is a threat to the success of clinical treatment. Besides high antimicrobial resistance rates, the presence of heterogeneous vancomycin-intermediate S. aureus (hVISA) and heterogeneous daptomycin-non-susceptible S. aureus (hDNSSA) in the hospital environment is underestimated and is associated with treatment failure. The aim of this study was to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacteriolysis
Share to Cell Wall

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Daptomycin

Share to Linezolid

Share to Methicillin-Resistant Staphylococcus aureus

Share to Oxazolidinones

Share to Tetrazoles

Share to Vancomycin

Source

Identifiers

PMID: 29753135
DOI: 10.1016/j.jgar.2018.05.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Daptomycin and vancomycin heteroresistance revealed among CC5-SCCmecII MRSA clone and in vitro evaluation of treatment alternatives.PMID 29753135Read ↗

Methicillin-resistant Staphylococcus aureus: related infections and antibiotic resistanceSemantic proximity Read ↗

In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.Semantic proximity Read ↗

Genetic profile of MRSA and MSSA clinical isolates with daptomycin MIC > 1 mg/LSemantic proximity Read ↗

Characteristics of glycopeptide-resistant Staphylococcus aureus strains isolated from inpatients of three teaching hospitals in Warsaw, Poland.Semantic proximity Read ↗

Molecular epidemiology of heteroresistant vancomycin-intermediate Staphylococcus aureus in Brazil.Semantic proximity Read ↗

Comparison of the clinical features, bacterial genotypes and outcomes of patients with bacteraemia due to heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-susceptible S. aureus.Semantic proximity Read ↗

Global distribution of heterogeneous vancomycin-intermediate Staphylococcus aureus strains (1997-2021): a systematic review and meta-analysis.Semantic proximity Read ↗

Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid.Semantic proximity Read ↗

Genomic insights on heterogeneous resistance to vancomycin and teicoplanin in Methicillin-resistant Staphylococcus aureus: A first report from South India.Semantic proximity Read ↗

Antimicrobial resistance in methicillin-resistant staphylococcus aureusSemantic proximity Read ↗

High prevalence of heteroresistance in Staphylococcus aureus is caused by a multitude of mutations in core genes.Semantic proximity Read ↗

Detection of heterogeneous vancomycin intermediate resistance in MRSA isolates from Latin AmericaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.